Search

everythinglearnresearchcommunity

for

Search:↓

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Caspases affect many cell functions and could help treat various diseases.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

ATP helps prevent skin damage from vandetanib by reducing stress.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Adiantum capillus extract reduces pain and swelling in animals.

Setipiprant did not significantly improve hair growth in men with hair loss.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

New progesterone-based compounds can block male hormones.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Upadacitinib effectively treats severe alopecia areata and is safe.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Atropine and neosynephrine effectively prevent floppy iris syndrome during cataract surgery.